Leonard Braden Michael Insider Trading Activity
Leonard Braden Michael has been net-selling over the last 12 months with 0 purchases and 7 sales across 3 different companies.
ADVM is the most-traded position with 4 trades. The largest single transaction was a sale of ADVM for $2.2M on Dec 4, 2025.
Performance Scorecard
Forward stock performance after each transaction by Leonard Braden Michael. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +11.4% | 75% | 8 |
| 90 days | — | +9.6% | 57% | 7 |
| 120 days | — | +3.3% | 29% | 7 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Leonard Braden Michael bought and sold ANTX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | ACRS | Sell | 300,000 | $4.53 | $1.4M | 10%+ Owner |
| Dec 4, 2025 | ADVM | Sell | 524,560 | $4.19 | $2.2M | 10%+ Owner |
| Dec 3, 2025 | ADVM | Sell | 222,925 | $4.17 | $930K | 10%+ Owner |
| Dec 2, 2025 | ADVM | Sell | 51,961 | $4.20 | $218K | 10%+ Owner |
| Dec 1, 2025 | ADVM | Sell | 300,000 | $4.20 | $1.3M | 10%+ Owner |
| Oct 3, 2025 | ASTC | Sell | 9,166 | $5.83 | $53K | 10%+ Owner |
| Oct 3, 2025 | ASTC | Sell | 220,410 | $7.13 | $1.6M | 10%+ Owner |
| May 30, 2025 | ANTX | Sell | 425,000 | $1.01 | $429K | 10%+ Owner |
| May 30, 2025 | ANTX | Sell | 7,000 | $1.03 | $7K | 10%+ Owner |
| May 28, 2025 | ANTX | Sell | 200,000 | $1.09 | $218K | 10%+ Owner |
| May 28, 2025 | ANTX | Sell | 2,000,000 | $1.16 | $2.3M | 10%+ Owner |
| May 28, 2025 | ANTX | Sell | 100,000 | $1.16 | $116K | 10%+ Owner |
Top Companies Traded
Other insiders at AN2 Therapeutics, Inc.
2 other tracked filers at ANTX.